Desoximetasone
Generic Name: desoximetasone
Brand Names:
Desoximetasone
Desoximetasone ointment USP, 0.05% contains 0.5 mg of desoximetasone USP per gram in a base of mineral oil and white petrolatum.
Overview
Desoximetasone ointment USP, 0.05% contains 0.5 mg of desoximetasone USP per gram in a base of mineral oil and white petrolatum.
Uses
Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage
Apply a thin film to the affected skin areas twice daily. Rub in gently.
Side Effects
Local adverse reactions reported infrequently include burning, itching, irritation, dryness, folliculitis, acneiform eruptions, and skin atrophy. In controlled trials, incidence was low (0.2%) with mild burning at application site.
Warnings
Contraindicated in patients with a history of hypersensitivity to any preparation components. Keep out of reach of children.
Pregnancy
Pregnancy Category C. Desoximetasone showed teratogenic effects in animal studies. Should be used during pregnancy only if potential benefit justifies fetal risk.
Storage
Store at 25 degrees C (77 degrees F); excursions permitted to 15 to 30 degrees C (59 to 86 degrees F).
Frequently Asked Questions
What is Desoximetasone used for?▼
Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
What are the side effects of Desoximetasone?▼
Local adverse reactions reported infrequently include burning, itching, irritation, dryness, folliculitis, acneiform eruptions, and skin atrophy. In controlled trials, incidence was low (0.2%) with mild burning at application site.
Can I take Desoximetasone during pregnancy?▼
Pregnancy Category C. Desoximetasone showed teratogenic effects in animal studies. Should be used during pregnancy only if potential benefit justifies fetal risk.
What are the important warnings for Desoximetasone?▼
Contraindicated in patients with a history of hypersensitivity to any preparation components. Keep out of reach of children.
Related Medications
Rilonacept
rilonacept
11 DESCRIPTION Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellular portions of the human interleukin-1 receptor component (IL-1R1) and IL-1 receptor accessory protein (IL-1RAcP) linked in-line to the Fc portion of human IgG1. Rilonacept has a molecular weight of approximately 251 kDa. Rilonacept is expressed in recombinant Chinese hamster ovary (CHO) cells.
Skin Protectant Gel
skin protectant gel
Purpose Skin Protectant
Anticoagulant Citrate Phosphate Dextrose (cpd) And As-5 Red Cell Preservative
anticoagulant citrate phosphate dextrose (cpd) and as-5 red cell preservative
11 DESCRIPTION The Reveos SELECT set has been evaluated for use with the Reveos system. The blood and fluid pathways of the blood bag set are steam-sterilized and are non-pyrogenic. The blood bag set is intended for use by appropriately trained phlebotomists who collect whole blood and by blood center personnel who process whole blood using the Reveos system. The formulas of the active ingredients are provided in Tables 1 and 2.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.